Clinical Trial Details


Research Study Summary

New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)


This is a 12 week treatment study to evaluate the efficacy of two doses of new medication compared to placebo in lowering pain intensity in patients with PHN. There is also a 9 month follow - up period for a total duration of 12 months.

Patient Inclusion Criteria:

  • Ages 18-80
  • Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)
  • Must be willing to wash out of chronic pain medication for the 12 week treatment period.

Patient Exclusion Criteria:

  • Must not have any other neuropathic pain

To Learn more

CW ID: 183365
Date Last Changed: October 6, 2015

Clinical Trial Snapshot

Both Male and Female
18 to 80 Years
Overall Status
12 Months
Facility Type


Alpine Clinical Research Center
3434 47th Street, Suite 201
Boulder, CO 80301
Phone: 303-443-7229

View Map

Research Center Information:

Alpine Clinical Research Center

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.